Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 5, 1998, Pages 469-474

  Qiu, Gui Xing ^a   Gao, Shu Neng ^b   Giacovelli, Giampaolo ^c   Rovati, Lucio ^c   Setnikar, Ivo ^c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c Rotta Research Laboratorium   (Italy)

Author keywords

CAS 15687 27 1; CAS 29031 19 4; Clinical studies; Glucosamine sulfate; Ibuprofen; Osteoarthritis; Safety; Viartril S

Indexed keywords

GLUCOSAMINE SULFATE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG; VIARTRIL S;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; FEMALE; GOOD CLINICAL PRACTICE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TABLET;

ADULT; AGED; ANTIRHEUMATIC AGENTS; FEMALE; GLUCOSAMINE; HUMANS; IBUPROFEN; KNEE; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN MEASUREMENT;

EID: 0040826909     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Altman, R., Brandt, K., Hochberg, M. et al., Osteoarthritis and Cartilage, 4, 217 (1996)
2. Bassleer, C., Henrotin, Y., Franchimont, P., Int. J. Tiss. Reac. 14, 231 (1992)
3. Bassleer, C., Reginster, J. Y., Franchimont, P., Rev. Esp. Reumatol. 20 (Suppl. 1), Mo95 (1993); abstr.
4. Giacovelli, G., Rovati, L., Rev. Esp. Reumatol. 20 (Suppl. 1), Mo96 (1993); abstr.
5. Giordano, N., Nardi, P., Senesi, M. et al., Clin. Ther. 147, 99 (1996)
6. Karzel, K., Domenjoz, R., Pharmacology 5, 337 (1971)
7. Lopez Vaz, A., Curr. Med. Res. Opin 8, 145 (1982)
8. MKcKenzie, L. S., Horsburgh, B. A., Gosh, P. et al., Lancet I, 980 (1976)
9. Müller-Fassbender, H., Bach, G. L., Haase, W. et al., Osteoarthritis Cartilage 2, 61 (1994)
10. Mund-Hoym, W. D., Therapiewoche 30, 5922 (1980)
11. Noak, W., Fischer, M., Förster, K. K. et al., Osteoarthritis Cartilage 7, 59 (1994)
12. Pujialte, J. M., Llavore, E. P., Ylescupidez, F. R., Curr. Med. Res. Opin 7, 110 (1980)
13. Rashad, S., Revell, P., Hemingway, A. et al., LANCET II, 519 (1989)
14. Reichelt, A., Förster, K. K., Fischer, M. et al., Arzneim.-Forsch./Drug Res. 44 (I), 75 (1994)
15. Richard, M., Vignon, E., Osteoarthritis Cartilage, accepted for publication
16. Rodén, L., Arkiv. för Kemi, 10, 345 (1956)
17. Rovati, L. C., Osteoarthritis Cartilage 5 (Suppl. A), 72 (1997)
18. Setnikar, I., Cereda, R., Pacini, M. A. et al., Arzneim.-Forsch./Drug Res. 41 (I), 157 (1991)
19. Snedecor, G. W., Cochran, W. G., Statistical methods, Seventh edition, p. 141-146, The Iowa State University Press, Ames, Iowa (1998)
20. Vajaradul, Y., Clin. Ther. 3, 336 (1981)
21. Vidal y Plana, R. R., Karzel, K., Fortschr. Med. 98, 801 (1980)
22. Vidal y Plana, R. R., Karzel, K., Fortschr. Med. 98, 555 (1980)